Preliminary Analysis of the Effects of Ad26.COV2.S Vaccination on CT Findings and High Intensive Care Admission Rates of COVID-19 Patients
On 27 February 2021, the Food and Drug Administration(FDA) authorized the administration of the adenovirus-based Ad26.COV2-S vaccine (J&J-Janssen) for the prevention of COVID-19, a viral pandemic that, to date, has killed more than 5.5 million people. Performed during the early phase of the COVI...
Main Authors: | Davide Negroni, Serena Carriero, Ilaria Passarella, Agnese Siani, Pierpaolo Biondetti, Antonio Pizzolante, Luca Saba, Giuseppe Guzzardi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Tomography |
Subjects: | |
Online Access: | https://www.mdpi.com/2379-139X/8/5/199 |
Similar Items
-
CT evaluations by emergency medicine specialists in Covid-19 patients
by: Kemal Gokcek, et al.
Published: (2021-09-01) -
Comparison of chest CT scan findings between COVID-19 and pulmonary contusion in trauma patients based on RSNA criteria: Established novel criteria for trauma victims
by: Hossein Abdolrahimzadeh Fard, et al.
Published: (2022-05-01) -
Diagnostic Performance of the Radiological Society of North America Consensus Statement for Reporting COVID-19 Chest CT Findings: A Revisit
by: Mohammed Hazem, et al.
Published: (2023-08-01) -
Woven EndoBridge in Wide-Neck Bifurcation Aneurysms: Digital Subtraction Angiography at 3-Year Follow-Up
by: Carmelo Stanca, et al.
Published: (2022-05-01) -
The automated Greulich and Pyle: a coming-of-age for segmental methods?
by: Rashmi Chapke, et al.
Published: (2024-03-01)